Meril Unveils New Surgical Products for Cardiovascular Portfolio
Meril, a global leader in medical devices and technology, has launched its latest range of surgical products portfolio for cardiovascular procedures, reinforcing its commitment to innovation and clinical excellence. The new product line aims to provide advanced solutions that enhance surgical precision and patient safety.
Here are the features and benefits of the newer cardiovascular portfolio:
Dafodil neo: The Dafodil Neo Pericardial Bioprosthesis is a biomechanically engineered valve with enhanced implantability, optimized hemodynamics, and advanced tissue matching, offering a unique solution for both aortic and mitral valve replacement.
Miltonia valve: The MILTONIA Bi-Leaflet Mechanical Heart Valve features durable Pyrolytic Carbon with Silicon alloying for thromboresistance and wear resistance, an open pivot design for passive washing, and a titanium-reinforced sewing cuff for precise implantation in aortic and mitral positions.
Filaprop: A blue polypropylene suture designed for high visibility during stitching, minimizing memory effect for smoother application.
Mericron XL: A braided polyester suture featuring oval-shaped pledgets to reduce tissue damage, ensuring enhanced tissue protection.
Meristeel: A stainless-steel monofilament suture available in various sizes, offering strength and reliability for different surgical needs.
Advanced Cardiac Suture Needles by Meril:
Hemovas Needles: Specially designed to minimize blood loss during blood vessel extraction, enhancing surgical precision.
V-Black Needles: Equipped with tissue and plexiglass penetrators, offering precise tissue penetration and reduced trauma.
C2 Calcified Coronary Needles: Engineered for improved penetration in calcified vessels, minimizing tissue damage and ensuring optimal results during coronary procedures.
Commenting on the launch, Meril’s CEO Vivek Shah claimed, “At Meril, we collaborate with surgical practitioners to address unmet surgical needs. This endeavor exemplifies our commitment towards development of innovative medical instruments.” ‘Our new products range in cardiovascular surgical procedures exemplifies our promise towards patient care.’
Dr S. Rajan, Chairman & HOD - Division of Cardiac Surgery, Madras Medical Mission Hospital said: "Meril’s cardiovascular portfolio brings together innovation and precision, from the advanced Filaprop stent to the reliable Meristeel for coronary interventions. The Dafodil Neo's biomechanical design is ideal for patients who require a minimally invasive valve replacement, while the Miltonia valve’s Pyrolytic Carbon and open pivot design help reduce thrombolytic events. Together, these products are setting a new standard in cardiovascular treatment, enabling faster recovery times and improved long-term results for patients."
Meril continues to be an innovation leader in medical technology through identifying, fulfilling, and implementing unmet clinical needs, and global healthcare knows it can count on Meril as a trusted partner.
Dr. Rajneesh Malhotra, Senior Director, Cardiac Sciences, Robotic Surgery, Cardiac Surgery (CTVS) commented, "The Meril cardiovascular portfolio, including the Dafodil Neo valve, offers groundbreaking advancements in heart valve technology. With its enhanced hemodynamics and minimally invasive design, the Dafodil Neo ensures faster recovery and better outcomes for patients. Combined with the durability of the Miltonia valve and the precision of Filaprop, these products are revolutionizing cardiovascular care and significantly improving quality of life for heart patients."
Meril continues to be an innovation leader in medical technology through identifying, fulfilling, and implementing unmet clinical needs, and global healthcare knows it can count on Meril as a trusted partner.